Peripheral blood samples from patients with OM and healthy controls were collected for PCR validation of the five key genes (SORT1, KIF1B, TMEM106B, NPC1, and ATP6V0B) identified through integrated bioinformatics and SHAP analyses. This evidence concerns the gene TMEM106B and ocular melanoma.